WINTON GROUP Ltd acquired a new position in shares of Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund acquired 1,315 shares of the biotechnology company's stock, valued at approximately $782,000.
Several other large investors have also modified their holdings of AXON. The Manufacturers Life Insurance Company increased its position in shares of Axon Enterprise by 0.6% during the third quarter. The Manufacturers Life Insurance Company now owns 43,643 shares of the biotechnology company's stock worth $17,440,000 after purchasing an additional 276 shares in the last quarter. Quantbot Technologies LP acquired a new position in Axon Enterprise during the third quarter worth approximately $84,000. Brooklyn Investment Group purchased a new stake in Axon Enterprise in the third quarter valued at approximately $41,000. Townsquare Capital LLC acquired a new stake in shares of Axon Enterprise in the third quarter valued at approximately $261,000. Finally, Zurcher Kantonalbank Zurich Cantonalbank grew its position in shares of Axon Enterprise by 13.1% during the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 50,492 shares of the biotechnology company's stock worth $20,177,000 after acquiring an additional 5,834 shares during the last quarter. Institutional investors and hedge funds own 79.08% of the company's stock.
Insider Buying and Selling
In other Axon Enterprise news, Director Jeri Williams sold 307 shares of the firm's stock in a transaction dated Monday, March 17th. The shares were sold at an average price of $552.72, for a total transaction of $169,685.04. Following the completion of the transaction, the director now directly owns 1,627 shares in the company, valued at approximately $899,275.44. This trade represents a 15.87 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of the company's stock in a transaction dated Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total transaction of $271,831.50. Following the completion of the sale, the director now directly owns 6,929 shares in the company, valued at $4,185,601.03. This trade represents a 6.10 % decrease in their position. The disclosure for this sale can be found here. 6.10% of the stock is currently owned by insiders.
Wall Street Analysts Forecast Growth
A number of analysts recently weighed in on AXON shares. Craig Hallum cut shares of Axon Enterprise from a "buy" rating to a "cautious" rating in a research note on Monday, March 10th. Barclays restated a "hold" rating on shares of Axon Enterprise in a research report on Monday, March 10th. The Goldman Sachs Group increased their price objective on Axon Enterprise from $500.00 to $700.00 and gave the stock a "buy" rating in a research report on Monday, January 27th. Robert W. Baird upped their price target on Axon Enterprise from $600.00 to $800.00 and gave the stock an "outperform" rating in a research note on Friday, December 6th. Finally, Northcoast Research downgraded Axon Enterprise from a "buy" rating to a "neutral" rating in a report on Wednesday, February 19th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and eleven have given a buy rating to the company. According to MarketBeat, the company has an average rating of "Moderate Buy" and an average target price of $604.67.
Get Our Latest Stock Analysis on Axon Enterprise
Axon Enterprise Price Performance
Axon Enterprise stock traded up $15.25 during mid-day trading on Tuesday, reaching $541.20. The company had a trading volume of 508,898 shares, compared to its average volume of 813,746. The company has a market capitalization of $41.47 billion, a P/E ratio of 139.85, a P/E/G ratio of 5.17 and a beta of 1.12. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63. The stock's 50-day simple moving average is $588.26 and its 200-day simple moving average is $551.61. Axon Enterprise, Inc. has a 1 year low of $273.52 and a 1 year high of $715.99.
Axon Enterprise Company Profile
(
Free Report)
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
Recommended Stories

Before you consider Axon Enterprise, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Axon Enterprise wasn't on the list.
While Axon Enterprise currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.